1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 2: 
Current and ideal decision rates in favor of intravenous alteplase overall and by evidence levela
EVT Level 1AEVT Level 2BEVT NGTotal
tPA level 1A
 Current85.1 (1408)85.0 (703)–85.0 (2111)
 Ideal82.1 (1359)83.0 (687)–82.4 (2046)
tPA level 2B
 Current77.5 (214)84.3 (697)52.0 (143)76.5 (1054)
 Ideal75.0 (207)80.5 (666)52.0 (143)73.7 (1016)
Total
 Current84.0 (1622)84.6 (1400)52.0 (143)82.0 (3165)
 Ideal81.1 (1566)81.8 (1353)52.0 (143)79.3 (3062)
  • Note:—NG indicates no guideline coverage; –, no responses in this category.
  • ↵a Case scenarios with guideline-based alteplase recommendation only. Data are (%) (No.).